Lucitanib

未知生产厂商

Lucitanib has been used in trials studying the treatment of ER+, MBC, SCLC, HER2+, and NSCLC, among others.

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Lucitanib has been used in trials studying the treatment of ER+, MBC, SCLC, HER2+, and NSCLC, among others.

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。